US Stock MarketDetailed Quotes

FATE Fate Therapeutics

Watchlist
  • 3.410
  • -0.160-4.48%
Close Jun 18 16:00 ET
388.17MMarket Cap-1776P/E (TTM)

Fate Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fate Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

1.93M

-96.74%
EPS(YoY)

-0.47

-147.37%
Analyst Rating

Buy

Jun 17, 2024

Fate Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.240M--
--2024/Q2-- / 1.548M--
May 9, 20242024/Q11.925M / 1.260M--
Feb 26, 20242023/Q41.676M / 1.528M--
Nov 8, 20232023/Q31.944M / 900.000K--
Aug 8, 20232023/Q2933.000K / 5.740M--
May 3, 20232023/Q158.980M / 33.529M--
Feb 28, 20232022/Q444.356M / 18.407M--
Nov 3, 20222022/Q314.981M / 15.486M--
Aug 3, 20222022/Q218.549M / 12.562M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.240M--
--2024/Q2-- / 1.548M--
May 9, 20242024/Q11.925M / 1.260M--
Feb 26, 20242023/Q41.676M / 1.528M--
Nov 8, 20232023/Q31.944M / 900.000K--
Aug 8, 20232023/Q2933.000K / 5.740M--
May 3, 20232023/Q158.980M / 33.529M--
Feb 28, 20232022/Q444.356M / 18.407M--
Nov 3, 20222022/Q314.981M / 15.486M--
Aug 3, 20222022/Q218.549M / 12.562M--

Unlock Free Earnings Estimates

Fate Therapeutics Earnings Reports

  • Fate Therapeutics | 10-Q: Quarterly report

    May 9 16:09 ET

  • Fate Therapeutics | 10-K: Annual report

    Feb 26 16:18 ET

  • Fate Therapeutics: Q3 2023 Earnings Report

    Nov 8, 2023 16:05 ET

  • Fate Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 17, 2024

    Buy

    • Buy

      33.33%

    • Hold

      60.00%

    • Sell

      6.67%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg